March 1, 2008


Hib Vaccination Increasing in Low-income Countries


The percentage of the world’s children who have been fully immunized against Haemophilus influenzae has increased substantially in the last several years, according to the Centers for Disease Control and Prevention (CDC).

In 1999, only 8 percent of the birth cohort received all three doses of the Hib vaccine. In 2006, that figure grew to 22 percent of the birth cohort. Those figures are expected to grow further as 23 additional countries are expected to introduce the vaccine in 2008.

The increase is an outgrowth of recent efforts by the public-private partnership the Global Alliance for Vaccines and Immunizations (GAVI). GAVI helps supply vaccines in countries with gross national incomes under $1,000 per capita.

GAVI started an initiative 2005 to accelerate adoption of Hib vaccine in GAVI-eligible countries. In 2004, 13 eligible countries were using the vaccine. By 2007 the figure had increased to 47. At least eight more applications are expected this year.

Success with the Hib vaccine suggests similar strategies may be effective to speed up introduction of new vaccines such as the rotavirus and pneumococcal vaccines.

The results appear in the Feb. 15 issue of Morbidity and Mortality Weekly Report.

< Previous Article | Next Article >

ACIP Makes New Recommendations on Flu, MMRV Vaccines
CID Supplement Provides New Insight on Clostridium difficile Infection
EIN Reports Cases of Hyperviscous Klebsiella pneumoniae with Liver Abscesses
IDSA E-mail Alerts: Ricin, Influenza, HIV/AIDS, Other ID Topics
Fluoroquinolone-resistant Meningococcus Reported
In the IDSA Journals
In Wake of Unusual Case, Immunization Experts Seek to Reassure Public about Vaccine Safety
Infection Prevention Brochure Updated
New Toolkit Helps Community Leaders Prepare for Pandemic Influenza
Hib Vaccination Increasing in Low-income Countries
Indonesia Sends WHO First H5N1 Samples in Months
President Announces Initiative to Fight Neglected Tropical Diseases
How to Code for Extra-long Subsequent Hospital Visits
IDSA Advocacy Update
NIAID Resistance Research Agenda, Shortcomings Highlighted in JID
Welcome, New IDSA Members!
Search Back Issues
Forward this Issue
Print-Friendly Version

Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA